News Releases

News and information from The Leukemia & Lymphoma Society

New Research for the Holidays Shows It Is Better to Give Than Receive

View full multimedia release here Rye Brook, NY Nov. 30, 2016 – A new national survey by The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary health non-profit dedicated to fighting blood cancers, finds that an overwhelming majority of Americans (90%) say they believe the true meaning of the holidays is to help others and 87% say they wish they could do more to help others in need. Eight in...

LLS Receives Prestigious Innovation Impact Award to “Reach the Unreached”

Rye Brook, NY – November 30, 2016 – The Leukemia & Lymphoma Society (LLS) was awarded the 2016 Celgene Innovation Impact award for an initiative that will allow the organization to “Reach the Unreached” with education and support for blacks, who are at twice the risk for multiple myeloma as whites. LLS’s initiative, “Taking it to Church: Enhancing Myeloma Knowledge and Access to Latest Treatments i...

LLS Invests $40.3 Million in New Research to Find Cures

View full multimedia release here   Rye Brook, NY – November 16, 2016 – The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cance...

MD Anderson Starts LLS-Funded Clinical Trial for Acute Myeloid Leukemia

Houston, TX- October 26, 2016 -- The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759. The study will enroll patients with acute myeloid leukemia (AML) and is supported by a $3.5 million investment from The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Progr...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: